Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01820494 · ClinicalTrials.gov registry record · NA

Nutritional Management of Infants With Chronic Diarrhea

A NA study of Growth and Tolerance Infant Study, sponsored by Abbott Nutrition.

Completed
Registry status
NA
Development phase
27
Enrollment target
3
Study locations

NCT01820494 is a NA study of Growth and Tolerance Infant Study that has completed, run by Abbott Nutrition. The registered enrollment target is 27 participants. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01820494, a NA study of Growth and Tolerance Infant Study, has completed, sponsored by Abbott Nutrition.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
3
Study locations

Study Summary

The study objective is to assess the growth of infants fed an experimental formula for the nutritional management of chronic diarrhea.

Interventions

  • OTHER Experimental Infant Formula

Study Locations (3)

Maryland

  • Johns Hopkins Hospital - Baltimore

Michigan

  • Children's Hospital of Detroit - Detroit

Nebraska

  • Children's Hospital - Omaha

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2000-10
Est. Completion 2002-11
Phase NA

Sponsor

Abbott Nutrition

89 total trials

What the Registry Record Tells You About NCT01820494

The ClinicalTrials.gov registry entry for NCT01820494 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Growth and Tolerance Infant Study appearing as the primary indexed condition, and to 1 intervention - of which Experimental Infant Formula is the first listed.

NCT01820494 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Maryland, Michigan, Nebraska.

Frequently Asked Questions

What is clinical trial NCT01820494 about?

NCT01820494 is a clinical study titled "Nutritional Management of Infants With Chronic Diarrhea". The study objective is to assess the growth of infants fed an experimental formula for the nutritional management of chronic diarrhea.

What is the current status of trial NCT01820494?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2000-10. Estimated completion is 2002-11.

What conditions does trial NCT01820494 study?

This clinical trial studies the following conditions: Growth and Tolerance Infant Study.

What interventions are being tested in trial NCT01820494?

The interventions under investigation include: Experimental Infant Formula (OTHER).

Who is sponsoring clinical trial NCT01820494?

This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01820494 being conducted?

This trial has 3 study locations across Maryland, Michigan, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.